Influenza A Vaccine (FP-01.1) Formulated With and Without Adjuvant, in the Presence or Absence of a Single Administration of a Trivalent Inactivated Influenza Virus Vaccine in Older Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions

Influenza A

Interventions

BIOLOGICAL

FP-01.1 + Placebo

BIOLOGICAL

FP-01.1 + TIV

BIOLOGICAL

FP-01.1-Adjuvant + Placebo

BIOLOGICAL

FP-01.1-Adjuvant + TIV

BIOLOGICAL

Adjuvant + TIV

BIOLOGICAL

Placebo + TIV

BIOLOGICAL

FP-01.1

BIOLOGICAL

FP-01.1-Adjuvant

OTHER

Placebo